Clinical Trial Update: Treating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant Radiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating TAS-102 chemotherapy in combination with neoadjuvant radiotherapy for locally advanced rectal cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Lonsurf (trifluridine/tipiracil)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rectal Cancer | Phase 2 | Status: RECRUITING